Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Apr 11:9:124.
doi: 10.3389/fendo.2018.00124. eCollection 2018.

The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis

Affiliations
Review

The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis

Keerthana Gnanapradeepan et al. Front Endocrinol (Lausanne). .

Abstract

The p53 tumor suppressor continues to be distinguished as the most frequently mutated gene in human cancer. It is widely believed that the ability of p53 to induce senescence and programmed cell death underlies the tumor suppressor functions of p53. However, p53 has a number of other functions that recent data strongly implicate in tumor suppression, particularly with regard to the control of metabolism and ferroptosis (iron- and lipid-peroxide-mediated cell death) by p53. As reviewed here, the roles of p53 in the control of metabolism and ferroptosis are complex. Wild-type (WT) p53 negatively regulates lipid synthesis and glycolysis in normal and tumor cells, and positively regulates oxidative phosphorylation and lipid catabolism. Mutant p53 in tumor cells does the converse, positively regulating lipid synthesis and glycolysis. The role of p53 in ferroptosis is even more complex: in normal tissues, WT p53 appears to positively regulate ferroptosis, and this pathway appears to play a role in the ability of basal, unstressed p53 to suppress tumor initiation and development. In tumors, other regulators of ferroptosis supersede p53's role, and WT p53 appears to play a limited role; instead, mutant p53 sensitizes tumor cells to ferroptosis. By clearly elucidating the roles of WT and mutant p53 in metabolism and ferroptosis, and establishing these roles in tumor suppression, emerging research promises to yield new therapeutic avenues for cancer and metabolic diseases.

Keywords: apoptosis; ferroptosis; metabolism; p53; tumor suppressor.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The role of wild-type (WT) p53 in metabolism. Genes positively regulated by p53 are shown in green, and genes negatively regulated by p53 are shown in red. p53 inhibits glucose transport, glycolysis, and fatty acid synthesis while it promotes lipid uptake, fatty acid oxidation, oxidative phosphorylation, and glutaminolysis.
Figure 2
Figure 2
The various roles of p53 in ferroptosis. Inhibition of glutathione peroxidase 4 (GPX4), the key enzyme that catalyzes the conversion of polyunsaturated fatty acids (PUFAs) containing peroxides to alcohols, is the key driver of ferroptosis. Depending on the context, p53 can suppress ferroptosis (such as in colorectal cancer cells) or promote ferroptosis. Mutant p53 sensitizes cells to ferroptosis even more than wild-type p53.

References

    1. Dolgin E. The most popular genes in the human genome. Nature (2017) 551(7681):427–31.10.1038/d41586-017-07291-9 - DOI - PubMed
    1. Mello SS, Attardi LD. Deciphering p53 signaling in tumor suppression. Curr Opin Cell Biol (2017) 51:65–72.10.1016/j.ceb.2017.11.005 - DOI - PMC - PubMed
    1. Humpton TJ, Vousden KH. Regulation of cellular metabolism and hypoxia by p53. Cold Spring Harb Perspect Med (2016) 6(7):211–30.10.1101/cshperspect.a026146 - DOI - PMC - PubMed
    1. Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell (2012) 149(5):1060–72.10.1016/j.cell.2012.03.042 - DOI - PMC - PubMed
    1. Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature (2015) 520(7545):57–62.10.1038/nature14344 - DOI - PMC - PubMed